News & AnalysisMaze Therapeutics rallies $190mMaze Therapeutics, a precision medicine company, has raised $190 million in funding.ByIris Dorbian10 January 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs